Skip Page Header

Home > WHO Study Group on Tobacco Product Regulation. Report on the scientific basis of tobacco product regulation: eighth report of a WHO study group.

WHO study group on tobacco product regulation. (2021) WHO Study Group on Tobacco Product Regulation. Report on the scientific basis of tobacco product regulation: eighth report of a WHO study group. Geneva: World Health Organization. WHO Technical Report Series, No. 1029. Licence: CC BY-NC-SA 3.0 IGO.

[img]
Preview
PDF (WHO study group on tobacco product regulation)
3MB

The outcomes and recommendations address a number of issues concerning novel and emerging nicotine and tobacco products, such as electronic nicotine delivery systems (ENDS), electronic non-nicotine delivery systems (ENNDS) and heated tobacco products (HTPs) and improves understanding of Member States on these products.

The study group reviewed nine background papers and two horizon scanning papers, specially commissioned for its tenth meeting, which addressed the following topics: 

  1. Toxicants in HTPs, exposure, health effects and claims of reduced risk (section 2);
  2. The attractiveness and addictive potential of HTPs: effects on perception and use and associated effects (section 3);
  3. Variations among HTPs, considerations and implications (section 4);
  4. Use of HTPs: product switching and dual or poly product use (section 5);
  5. Regulations on HTPs, ENDS and ENNDS, with country approaches, barriers to regulation and regulatory considerations (section 6);
  6. Estimation of exposure to nicotine from use of ENDS and from conventional cigarettes (section 7);
  7. Exploration of methods for quantifying individual risks associated with ENDS, ENNDS and HTPs: impact on population health and implications for regulation (section 8).
  8. Flavours in novel and emerging nicotine and tobacco products (section 9);
  9. Global marketing and promotion of novel and emerging nicotine and tobacco products and their impacts (section 10);
  10. Forms of nicotine in tobacco plants, chemical modifications and implications for ENDS products (section 11); and
  11. EVALI: “e-cigarette or vaping product use-associated lung injury” (section 12).

The Study Group’s recommendations seek to promote international coordination of regulatory efforts, the adoption of best practices in product regulation and strengthen product regulation capacity-building across all WHO regions. This report is a ready resource to Member States, based on sound science and support the implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC) by its States Parties. 

The report, which is a WHO global public health good will complement the global efforts to strengthen the implementation of WHO FCTC (target 3a of the Sustainable Development Goals), thereby helping reduce tobacco use and improve overall public health at country, regional and global level. 

Each chapter of the report has been summarized for regulators to support policy action at country level based on the evidence-based recommendations of the report.  

See also, 

Litigation relevant to regulation of novel and emerging nicotine and tobacco products – case studies

Litigation relevant to regulation of novel and emerging nicotine and tobacco products: Comparison across Jurisdictions

Item Type
Report
Publication Type
International, Guideline, Report
Drug Type
Tobacco / Nicotine
Intervention Type
Policy
Source
Date
May 2021
Identification #
WHO Technical Report Series, No. 1029. Licence: CC BY-NC-SA 3.0 IGO
Pages
334 p.
Publisher
World Health Organization
Corporate Creators
WHO study group on tobacco product regulation
Place of Publication
Geneva
EndNote
Related (external) link

Repository Staff Only: item control page